INTEGRATED INTERNET-BASED COGNITIVE BEHAVIOURAL THERAPY (I-CBT) AND INTRAVENOUS KETAMINE FOR SUICIDALITY IN TREATMENT-RESISTANT DEPRESSION: A RANDOMIZED, MIDAZOLAM-CONTROLLED CLINICAL TRIAL
- Registry ID
- 21-6000
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- UNIVERSITY HEALTH NETWORK
- Start date
- 2023-07-31
- Last update
- 2021-12-03
Conditions
- MAJOR DEPRESSIVE DISORDER
- SUICIDALITY
Related clinical trials
- A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ADJUNCTIVE TREATMENT WITH BRENIPATIDE IN DELAYING TIME TO RELAPSE COMPARED WITH PLACEBO IN ADULT PARTICIPANTS WITH MAJOR DEPRESSIVE DISORDER (RENEWMDD-1)
- PSILOCYBIN-ASSISTED PSYCHOTHERAPY FOR MAJOR DEPRESSIVE DISORDER IN WOMEN WITH A HISTORY OF CHILDHOOD MALTREATMENT: A PILOT TRIAL
- 18F]BCPP-EF PET IMAGING OF MITOCHONDRIAL COMPLEX I IN MAJOR DEPRESSIVE DISORDER, TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER, AND LONG COVID (PASC)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE
MAINTENANCE OF EFFECT OF NBI-1065845 AS AN ADJUNCTIVE TREATMENT
IN SUBJECTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF
NBI-1065845 AS ADJUNCTIVE TREATMENT IN SUBJECTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
- PSILOCYBIN-ASSISTED THERAPY FOR COMORBID MAJOR DEPRESSIVE DISORDER AND ALCOHOL USE DISORDER: A PILOT RANDOMIZED CLINICAL TRIAL
View on source registry